ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Physician Assistant

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,544Medicare Part D Prescriptions Filled, Including Refills

Rank: 23 out of 1058

$710K Total Retail Price of All Prescriptions

Rank: 22 out of 1058

405 Patients Receiving at Least One Drug in Part D
62% Patients 65 Years and Older
66% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in North Carolina
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

24% of this provider’s 405 patients filled at least one prescription for a schedule two drug, compared to an average of 12%.

Schedule Three
Controlled Substances

19% of this provider’s 405 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 19%.

Prescription Price

$74 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 8.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
HYDROCODONE-ACETAMINOPHEN 292 142 63 S3 1 1
OMEPRAZOLE 291 171 70 2 2
ALPRAZOLAM 263 68 50 B 3 13
FUROSEMIDE 231 143 68 4 9
OXYCODONE HCL 214 38 46 S2 5 11
LISINOPRIL 205 142 56 6 3
SIMVASTATIN 190 134 50 7 5
METFORMIN HCL 163 89 36 8 10
AMLODIPINE BESYLATE 155 139 46 9 4
PREDNISONE 150 82 100 10 28
GABAPENTIN 149 53 46 11 7
OXYCODONE HCL-ACETAMINOPHEN 143 11 25 S2 12 12
LORAZEPAM 142 103 35 B 13 29
TRAMADOL HCL 137 46 24 14 15
DIAZEPAM 112 34 25 B 15 69
METOPROLOL SUCCINATE 110 99 26 16 19
ZOLPIDEM TARTRATE 104 23 17 17 20
OXYCODONE-ACETAMINOPHEN 103 32 28 S2 18 17
FENOFIBRATE* 100 56 23 19 90
PROAIR HFA 100 20 28 19 39
NEXIUM 99 15 22 21 23
LEVOTHYROXINE SODIUM 97 59 27 22 6
ESCITALOPRAM OXALATE 96 54 22 23 70
METOPROLOL TARTRATE 94 65 25 24 18
ATORVASTATIN CALCIUM 89 64 22 25 8
METFORMIN HCL ER 82 55 18 26 52
FLUTICASONE PROPIONATE 71 34 20 27 30
CLONAZEPAM 71 18 18 B 27 21
SPIRIVA 70 17 19 29 49
CITALOPRAM HBR 69 46 21 30 33
POTASSIUM CHLORIDE 69 39 19 30 24
AZITHROMYCIN 68 36 51 32 46
CYCLOBENZAPRINE HCL 68 12 21 R 32 41
CELEBREX 66 20 15 34 83
WARFARIN SODIUM 65 51 13 35 31
GLIPIZIDE 61 42 14 36 95
ADVAIR DISKUS 61 <11 13 36 55
ALLOPURINOL 61 56* 19 36 58
FINASTERIDE 60 44 16 39 94
RANITIDINE HCL 59 28 18 40 59
LANTUS SOLOSTAR 58 24 12 41 82
DONEPEZIL HCL 57 52* 17 42 56
PROMETHAZINE HCL 56 <11 16 R 43 86
SYNTHROID 56 <11 <11 43 57
HYDROCHLOROTHIAZIDE 56 39 16 43 14
LABETALOL HCL 55 41 16 46 353
ACYCLOVIR 54 11 14 47 355
PANTOPRAZOLE SODIUM 53 26 15 48 35
AMOXICILLIN 50 30 41 49 88
TRAZODONE HCL 50 <11 11 49 34
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 22, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.